All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 161 of 206 pages ‹ First < 159 160 161 162 163 > Last ›
HSL2168
Should there be systems in place to educate students and residents on appropriate interactions with pharmaceuticals? If so, what should they be?
AAMC Reporter 2001 Jul 10
HSL2170
Rx's and RSVP's: Pharmaceutical Companies Holding More Physician Meetings and Events
Business Wire 2001 Jul 9
HSL2172
Dippenaar J.
The Pharmaceutical Invasion
Meridian Healthcare 2001 Jul 9
HSL2169
Lowe R, Baumann B.
Does conflict of interest impact speaker credibility?
Canadian Associati0on of Emergency Physicians 2001 Jul 013:(3):
http://www.caep.ca/page.asp?id=003261D25B654D3BA70F622628788B2C
HSL4843
Thawani V.
Drug samples are meant for advertising.
Issues Med Ethics 2001 Jul-Sep;9:(3):91
HSL7807
Vivian JC.
State prescription drug benefit plans
US Pharmacist 2001 Jul;26:46, 51-52, 55
HSL19527
Off the Charts: Pay, Profits, and Spending by Drug Companies
2001 July
http://www.actupny.org/reports/drugcosts.html
HSL20009
Liberman S
Hard-sell havoc
Australian Doctor 2001 Jun 2926
HSL20155
Howe M
Push for consumer ads rejected
Australian Doctor 2001 Jun 2923
HSL2167
Lenzer J.
The Benefit of the Bargain
Praxis Post 2001 Jun 27
HSL19990
Berwick DM
The World has AIDS, So make the Medicines Free
The International Heerald Tribune 2001 Jun 27
HSL2508
Wright J.
The value of industry-sponsored studies of initial antihypertensive therapies (2nd of 2 letters)
Canadian Medical Association Journal 2001 Jun 26;164:(13):1832-3
HSL2570
Caro JJ, Payne K.
The value of industry-sponsored studies of initial antihypertensive therapies (1st of 2 letters)
Canadian Medical Association Journal 2001 Jun 26;164:(13):1832
HSL20114
States Take aim at direct-to-consmer drug ads
Scott-Levin 2001 Jun 25
http://www.thefreelibrary.com/Scott-Levin+Announces+States+Take+Aim+at+Direct-to-Consumer+Drug+Ads.-a075878639
HSL19528
Angell M, Relman AS
Prescription for Profit
The Washington Post 2001 Jun 20
http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&node=digest&contentId=A21428-2001Jun19
HSL18004
Commens CA.
Truth in clinical research trials involving pharmaceutical sponsorship.
Med J Aust 2001 Jun 18;174:(12):648-9
http://www.mja.com.au/public/issues/174_12_180601/commens/commens.html
HSL19529
Romano M
Prescription for conflict. AMA accepts funding from drug firms for campaign.
Mod Healthc. 2001 Jun 18;31:(25):14
http://www.ncbi.nlm.nih.gov/pubmed/11436381
HSL20140
Tanner L
US doctors want AMA to seek ban on prescription drug ads for consumers
The Daily Gazette 2001 Jun 17
http://www.thebody.com/content/art20398.html
HSL6976
Silversides A.
Hospital denies that withdrawal of MD's job offer was related to drug-company funding
Canadian Medical Association Journal 2001 Jun 16;164:(13):1879
HSL17371
Boseley S
Swallowing the company line
The Guardian 2001 Jun 14
http://www.guardian.co.uk/education/2001/jun/14/highereducation.uk
HSL2165
Silversides A.
Health Canada "reinterprets" laws about prescription drug ads for consumers
http://www.straightgoods.com/item456.asp 2001 Jun 11
HSL2164
Hilts P.
Jury Awards $6.4 Million In Killings Tied to Drug
The New York Times 2001 Jun 8
HSL20143
Cassels A
A tough advertising pill to swallow
The Ottawa Citizen 2001 Jun 7
HSL20110
Landon L
Pushing drugs
The Ottawa Citizen 2001 Jun 56
HSL20107
Sanders C
Drug company ads targeting consumers hit
Winnipeg Free Press 2001 Jun 2
HSL19962
Lisker W
The Heartbreak of Drug Pricing
Annals of Internal Medicine 2001 Jun 1;134:(11):1068
http://www.annals.org/content/136/11/853.2.extract
HSL20130
Direct-to-consumer prescription drug advertising
Working Group on Women and Health Protection 2001 Jun 1
HSL1850
Marcoux H, Lamontagne C, Cayer S, Desrochers A, Gauthier D.
[The development of ethics. Identifying what training in medical ethics is needed by family physicians]
Can Fam Physician 2001 Jun;47:1208-15
HSL2166
Demoro D.
The nursing shortage & the drug connection.
Revolution 2001 Jun
http://www.ncbi.nlm.nih.gov/pubmed/12018055
HSL2549
Mintzes B, Kazanjian , Bassett K, Lexchin J.
Untitled
2001 Jun;
www.chspr.ubc.ca//hpru/pdf/dtca-v4-expertsurvey.pdf
HSL2572
Bero L.
'Educational' advertisements - I haven't seen one yet!
Western Journal of Medicine 2001 Jun;174:395
HSL7888
Kinard ME.
Key components responsible for increasing drug costs
ASHP Annual Meeting 2001 Jun;58:
HSL7889
Jackimiec JM.
Communicating utilization and critical issues to health providers
ASHP Annual Meeting 2001 Jun;58:
HSL7891
Kostek NE.
Use of pharmacy carve-outs as a managed care strategy to recover pharmacy costs and generate revenues in an acute care setting
ASHP Annual Meeting 2001 Jun;58:
HSL16132
Sheftell F, Dodick D, Cady R.
Direct-to-consumer advertising of OTC agents under current ftc regulations: concerns and comment.
Headache 2001 Jun;41:(6):534-6
http://www3.interscience.wiley.com/journal/119014591/abstract?CRETRY=1&SRETRY=0
HSL2158
Jackson T.
Are you being duped?
BMJ 2001 May 26;322:1312
http://bmj.bmjjournals.com/cgi/content/full/322/7297/1312
HSL2304
Ramsay S.
Online database reveals researchers' industry ties.
Lancet 2001 May 26;357:(9269):1677
http://linkinghub.elsevier.com/retrieve/pii/S0140673600048625
HSL5593
Shann F.
Uses of error: the wrong research costs lives.
Lancet 2001 May 26;357:(9269):1691
http://linkinghub.elsevier.com/retrieve/pii/S0140673600048790
HSL5310
Bailar JC 3rd.
The powerful placebo and the Wizard of Oz.
N Engl J Med 2001 May 24;344:(21):1630-2
http://content.nejm.org/cgi/content/extract/344/21/1630
HSL14757
Bye-bye commercial bias
The Australian 2001 May 23
HSL14776
Blumenstyk G.
Declarations of dependence
The Australian 2001 May 23
HSL2163
Chemist conflict demands scrutiny
The Australian Edition 2001 May 22
HSL2162
Bryden-Brown S.
Drug giants underwrite chemists
The Weekend Australian 2001 May 193
HSL13271
Prescription drugs, Protection racket: Drug patent-holders under pressure
The Economist (US) 2001 May 194
http://www.economist.com/business/displaystory.cfm?story_id=E1_GNSQQG
HSL17370
O'Brien M
Preparing For A Campaign
Science and Environmental Health Network 2001 May 18
HSL2306
Zitner D.
Prescription data
Canadian Medical Association Journal 2001 May 15;164:(10):1408-1409
HSL2319
Short , S .
Prescription data
CMAG 2001 May 15;164:(10):1408
HSL2320
Nucci , C .
One hundred pennies for your thoughts
Canadian Medical Association Journal 2001 May 15;164:(10):1407
HSL2321
Korman , R .
Prescription data
CMAJ 2001 May 15;164:(10):1408
HSL2322
Hammell , D .
One hundred pennies for your thoughts
CMAJ 2001 May 15;164:(10):1408
HSL2373
The Editor.
One hundred pennies for your thoughts
CMAJ 2001 May 15;164:(10):1407
HSL2506
Zoutman DE, Ford BD, Bassili AR.
Prescription data (5th of 5 letters)
Canadian Medical Association Journal 2001 May 15;164:(10):1409-1410
HSL2538
Short S.
Prescription data (2nd of 5 letters)
Canadian Medical Association Journal 2001 May 15;164:(10):1408
HSL2544
Nucci C.
One hundred pennies for your thoughts (1st of 2 letters)
Canadian Medical Association Journal 2001 May 15;164:(10):1407
HSL2557
MacLeod S.
Prescription data (4th of 5 letters)
Canadian Medical Association Journal 2001 May 15;164:(10):1409
HSL2559
Korman R.
Prescription data (1st of 5 letters)
Canadian Medical Association Journal 2001 May 15;164:(10):1408
HSL2564
Hammell D.
One hundred pennies for your thoughts (2nd of 2 letters)
Canadian Medical Association Journal 2001 May 15;164:(10):1407
HSL2569
Editor of CMAJ
One hundred pennies for your thoughts (response)
Canadian Medical Association Journal 2001 May 15;164:(10):1407
HSL20108
MacKinaly S
Feds should squelch drug ads, meeting told
The Daily News 2001 May 15
HSL20142
Hourihan J
Prescription-drug ads endangering Canadian's health, conference told
Halifax Chronicle-Herald 2001 May 15
HSL19532
Pear R
Spending on Prescription Drugs Increases by Almost 19 Percent
The New York Times 2001 May 8
http://www.nytimes.com/2001/05/08/us/spending-on-prescription-drugs-increases-by-almost-19-percent.html
HSL20363
Charatan F
Doctors say they are not influenced by drug companies' promotions
BMJ 2001 May 5;322:(7294):1081
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120227/
HSL2324
Peterson , R G.
Cisapride and patient information leaflets
CMAJ 2001 May 1;164:(10):1278
HSL2325
Muller , P .
Cisapride and patient information leaflets
CMAJ 2001 May 1;164:(9):1278
HSL2326
Arnott , W .
Cisapride and patient information leaflets
CMAJ 2001 May 1;164:(9):1278
HSL2507
Zitner D.
Prescription data (3rd of 5 letters)
Canadian Medical Association Journal 2001 May 01;164:(10):1408-9
HSL2512
Sukkari S, Sasich , L .
Cisapride and patient information leaflets (1st of 4 letters)
Canadian Medical Association Journal 2001 May 1;164:(9):1276-1278
HSL2541
Peterson R.
Cisapride and patient information leaflets (4th of 4 letters)
Canadian Medical Association Journal 2001 May 1;164:(9):1278-9
HSL2546
Muller P.
Cisapride and patient information leaflets (3rd of 4 letters)
Canadian Medical Association Journal 2001 May 1;164:(9):1278
HSL2573
Arnott W.
Cisapride and patient information leaflets (2nd of 4 letters)
Canadian Medical Association Journal 2001 May 1;164:(9):1278
HSL35
Stout E.
Doctoring sales
Sales & Marketing Management 2001 May;52-60
HSL1851
Steinman MA, Shlipak MG, McPhee SJ.
Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
Am J Med 2001 May;110:(7):551-7
http://linkinghub.elsevier.com/retrieve/pii/S000293430100660X
HSL2095
Kluger AN, Tikochinsky J.
The error of accepting the "theoretical" null hypothesis: the rise, fall, and resurrection of commonsense hypotheses in psychology.
Psychol Bull 2001 May;127:(3):408-23
http://content.apa.org/journals/bul/127/3/408
HSL7410
Gutknecht DR.
Evidence-based advertising?: A survey of four major journals.
J Am Board Fam Pract. 2001 May-Jun;14(3):197-200. 2001 May-Jun;14:(3):197-200
http://www.jabfm.org/cgi/reprint/14/3/197
HSL7802
Mudryj L, Richardson H.
Cyber prescriber
New Zealand Pharmacy 2001 May;21:(33):
HSL7819
Gannon K.
Manufacturers share their thoughts about pharmacists
Hospital Pharmacist Report 2001 May;15:35-36
HSL18005
Berger JT, Kark P, Rosner F, Packer S, Bennett AJ.
Direct-to-consumer drug marketing: public service or disservice?
Mt Sinai J Med 2001 May;68:(3):197-202
http://www.ncbi.nlm.nih.gov/pubmed/11373692
HSL18006
Hassan F.
Being a modern pharmaceutical company: new paradigms for the pharmaceutical industry.
Clin Pharmacol Ther 2001 May;69:(5):281-5
http://www.ncbi.nlm.nih.gov/pubmed/11371995
HSL20523
Harris G
AIDS Gaffes in Africa Come Back To Haunt Drug Industry in the U.S.
The Wall Street Journal 2001 Apr 23
http://online.wsj.com/article/SB987984200345114882.html
HSL2561
Hogh B, Clarke PD, Camus D, Chulay JD.
Efficacy of atovaquone-proguanil? (2nd of 2 letters)
The Lancet 2001 Apr 21;357:1289-1290
HSL2567
Croft A, Geary K, Morgan L.
Efficacy of atovaquone-proguanil? (1st of 2 letters)
The Lancet 2001 Apr 21;357:1289
HSL2021
McIlroy A.
Article censored that decried placebo use in drug trials
The Globe and Mail 2001 Apr 18
HSL7840
Relman AS.
Separating continuing medical education from pharmaceutical marketing.
JAMA 2001 Apr 18;285:(15):2009-12
http://jama.ama-assn.org/cgi/content/full/285/15/2009
HSL7842
Holmer AF.
Industry strongly supports continuing medical education.
JAMA 2001 Apr 18;285:(15):2012-4
HSL7838
Cassell D.
How manufacturers view pharmacists
Drug Topics 2001 Apr 16;145:47-48, 50, 52, 54
HSL2372
Kiln , M .
Industry-sponsored research
The Lancet 2001 Apr 14;357:1209-1210
HSL2565
The tightening grip of big pharma
Lancet 2001 Apr 14;357:(9263):1141
http://linkinghub.elsevier.com/retrieve/pii/S0140673600043634
HSL2676
Anonymous .
Rebirth of a salesman
The Economist 2001 Apr 14
HSL20126
Jennings L
Justification easy for influenza campaign
New Zealand Doctor 2001 Apr 118
HSL2371
Kondro W.
Canadian university publishes new rules to protect scientists.
Lancet 2001 Apr 7;357:(9262):1104
http://linkinghub.elsevier.com/retrieve/pii/S0140673600043221
HSL7843
Gebhart F.
Annual Rx survey: behind the numbers
Drug Topics 2001 Apr 2;145:48-50, 52, 55
HSL1852
Sluzki CE.
Drug-company influence on medical education in the U.S
Am J Orthopsychiatry. 2001 Apr;71:(2):148-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11347356&query_hl=7
HSL1853
Johnson RG.
Physician education and the pharmaceutical industry.
Chest 2001 Apr;119:(4):995-6
http://www.chestjournal.org/cgi/content/full/119/4/995
HSL2369
Franklin , A .
Pharmaceutical companies and CME
OMR 2001 Apr;68:(4):10
HSL2370
Goodman B.
Do drug company promotions influence physician behavior?
West J Med 2001 Apr;174:(4):232-3
HSL7812
TI: Joint statement from CP and PGEU: Prescription-only medicines should not be advertised directly to the public
Farmaceutski Glasnik 2001 Apr;57:153-154
HSL18007
Varkey B.
Time for introspection.
Chest 2001 Apr;119:(4):1255-6
http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11296195
HSL18008
Lever A.
Considerations in the Relationship Between the American College of Chest Physicians and Industry
Chest 2001 Apr;119:(4):1257-9.
http://chestjournal.chestpubs.org/content/119/4/1257.long
HSL2365
Lo B, Wolf L .
Conflict-of-interest policies
NEJM 2001 Mar 29;344:(13):1018
HSL2366
McCrary , S. V, L B.Brody, B A.
Conflict-of-interest policies
NEJM 2001 Mar 29;344:(13):1018
Page 161 of 206 pages ‹ First < 159 160 161 162 163 > Last ›
